Does BREXPIPRAZOLE Cause Product use issue? 434 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 434 reports of Product use issue have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 3.3% of all adverse event reports for BREXPIPRAZOLE.
434
Reports of Product use issue with BREXPIPRAZOLE
3.3%
of all BREXPIPRAZOLE reports
35
Deaths
12
Hospitalizations
How Dangerous Is Product use issue From BREXPIPRAZOLE?
Of the 434 reports, 35 (8.1%) resulted in death, 12 (2.8%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 434 reports have been filed with the FAERS database.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Suicidal ideation (427)
Depression (413)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which BREXPIPRAZOLE Alternatives Have Lower Product use issue Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE